Dose volume analysis of radiotherapy for inoperable patients with stage 1-2 endometrial carcinoma

DOI PDF Web Site 被引用文献1件 参考文献48件
  • OHKUBO Yu
    Hidaka Hospital
  • KATO Shingo
    Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
  • KIYOHARA Hiroki
    Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
  • TSURUOKA Ichiro
    Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
  • TAMAKI Tomoaki
    Applied Radiation Biology and Radiotherapy Section, International Atomic Energy Agency
  • NODA Shin-ei
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • OHNO Tatsuya
    Gunma University Heavy Ion Medical Center
  • NAKANO Takashi
    Department of Radiation Oncology, Gunma University Graduate School of Medicine

書誌事項

タイトル別名
  • Dose Volume Analysis of Radiotherapy for Inoperable Patients with Stage I-II Endometrial Carcinoma

この論文をさがす

抄録

This study aims to assess the efficacy and toxicity of definitive radiotherapy for early-stage endometrial carcinoma. The correlation between CT-based dosimetric parameters and clinical outcomes is also evaluated. Between 2002 and 2006, 10 medically inoperable patients with T1-2 endometrial carcinoma were treated with radiotherapy alone. A combination of external beam radiotherapy (EBRT) and high-dose-rate intracavitary brachytherapy (HDR-ICBT) was used for 9 patients, and one was treated with HDR-ICBT alone. Dose prescription of HDR-ICBT was determined in reference to CT images at brachytherapy, and a total dose of 22–24 Gy in 4 fractions was delivered to the outer perimeter of the uterine corpus. Dose-volume parameters of the gross tumor volume (GTV), clinical target volume (CTV), and organs at risk were assessed retrospectively using the dose-volume histograms derived from the CT image-based treatment planning system. After a median follow-up of 55 months, 9 patients were alive without evidence of recurrence. One patient died from liver cirrhosis 17 months after radiotherapy. Severe acute and late toxicities were not observed in any of the patients. Average minimum dose to 90% of GTV and CTV (D90) was 88.0 and 45.9 GyEQD2, respectively. The minimum dose delivered to 2 cc of the most irradiated volumes of the rectum and sigmoid colon (D2cc) was 78.9 and 65.9 GyEQD2, respectively. These patients developed Grade 1 late complications. In this study, stage I–II endometrial carcinoma was well-controlled locally with minimum late toxicity by radiotherapy alone with HDR-ICBT. 3D image-based brachytherapy may potentially deliver a sufficiently high dose to the whole tumor without significant increase in dose to surrounding normal tissues.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (48)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ